《亞洲股市》日經及滬韓馬港股升1%-1.6% 惟印尼及紐股反覆逆軟
阿思達克 08-24 12:06
美國8月Markit綜合產出指數初值連跌三個月至55.4創八個月低遠差預期，投資者料聯儲局短期內不會「收水」，加上輝瑞與BioNTech合作研發新冠疫苗正式獲美國當局批準全面使用，紓緩對美國近期確診病例激增憂慮，油價急彈逾半成結束七連跌，金屬價格也全面上揚，美股昨晚在銀行、工業、能源及晶片板塊受捧帶動全面續升0.6%-1.55%，納指及標普跑贏三連漲兼再創紀錄高。美股期貨全面續升不足0.2%。亞太區股市普遍造好，韓股及吉隆坡綜合指數續升1.5%，分別報3,136及1,545；日經高見27,817，現報27,768，續升1%。滬指及深成半日收3,511及14,660，續升1%及0.9%。
港股由逾八個月低位連彈第二天，今天在比亞迪(01211.HK)、小米(01810.HK)、瑞聲(02018.HK)、碧桂園(06098.HK)、重磅股騰訊(00700.HK)、已九連跌屢尋底阿裏巴巴(09988.HK)、海底撈(06862.HK)、中績多賺1.5倍的藥明生物(02269.HK)、受益於澳門放寬入境檢測陰性期限的濠賭股銀娛(00027.HK)/金沙(01928.HK)，以及美團(03690.HK)升逾2%-9%帶動，曾急漲493點或近2%高見25,603，現報25,501，續升392點或近1.6%。
新加坡海峽時報指數及菲股回升0.7%及0.9%，分別報3,109及6,652。昨天急彈近2.5%的臺股高見16,904遇壓，現報16,817，續升近0.5%；泰股續升0.7%報1,593。越南扭兩連挫，回升0.3%報1,302。澳洲200續彈0.3%報7,514。印度孟買續升0.2%報55,676。
不過，印尼扭兩連漲，今早反覆(曾高見6,138)回吐0.4%報6,082；新西蘭50指數承昨天破頂強勢，今早進一步升至13,150屢創紀錄高遇阻，掉頭倒跌0.1%報13,052。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
More Content
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
